This inventor holds 1 USPTO granted patent, plus 3 CIPO patents. Top assignee: Nextgen Bioscience Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Young Ah Shin: Innovator in Gonadotropin Releasing Hormone Research
Introduction
Young Ah Shin is a notable inventor based in South Korea, recognized for his contributions to the field of pharmaceutical sciences. His work primarily focuses on developing treatments for various sex hormone-related diseases. Despite having 1 patents, his research has significant implications for medical advancements.
Latest Patents
One of Young Ah Shin's key inventions is titled "Gonadotropin Releasing Hormone Receptor Antagonists, Method for the Preparation Thereof and Pharmaceutical Composition Comprising the Same." This invention provides gonadotropin releasing hormone receptor antagonists of Formula (I) and a pharmaceutical composition that can be beneficial in preventing or treating a range of conditions. These conditions include endometriosis, amenorrhea, irregular menstruation, uterine myoma, and several others, including Alzheimer disease.
Career Highlights
Throughout his career, Young Ah Shin has focused on innovative solutions to complex medical issues. His research has the potential to improve the quality of life for individuals suffering from hormone-related disorders. His dedication to advancing medical science is evident in his work.
Collaborations
Young Ah Shin has collaborated with esteemed colleagues, including Seon-Mi Kim and Jae-Sun Kim. These partnerships have enhanced the scope and impact of his research, contributing to the development of effective treatments.
Conclusion
In summary, Young Ah Shin is a dedicated inventor whose research in gonadotropin releasing hormone receptor antagonists holds promise for treating various medical conditions. His contributions to pharmaceutical sciences are noteworthy and reflect his commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile